SAN FRANCISCO—Orteronel — a non-steroidal selective inhibitor of 17,20-lyase — did not achieve a significant improvement in overall survival in 1099 patients randomised to treatment with this “abiraterone-like” agent in comparison with...
The rare, fatal lympho-proliferative condition: Multicentric Castleman’s Disease — MCD — could soon be treatable following findings announced at the American Society of Hematology annual meeting in New Orleans. Dr. Raymond S Wong MD, PhD — who...
LONDON— Researchers have shown that endometrial cancer — and hopefully ovarian cancer too — could potentially be detected much earlier than at present — or even prevented altogether — by looking for ‘silencing’ by DNA methylation of the...
NEW ORLEANS—High remission rates with extended survival are being achieved in patients who had failed all other therapies — including allogeneic stem cell transplantation — for their acute lymphoblastic leukemia and otherwise had very short life...
AMSTERDAM—Women with HER-2 positive metastatic breast cancer had significantly improved time to progression with fewer side effects after treatment with the antibody-drug conjugate T-DM1 compared to conventional therapies in the phase three TH3RESA...
LONDON— Intraoperative radiotherapy given at the time of lumpectomy was found to be ‘non-inferior’ to the use of conventional post-operative whole breast external beam radiotherapy and had equivalent breast cancer specific mortality but...
AMSTERDAM—Screening men and women for colorectal cancer (CRC) with either fecal occult blood testing (FOBT) or endoscopy markedly lowered disease incidence and mortality in a study of screening patterns in 11 European countries over the last 20...
AMSTERDAM—Locoregional radiotherapy to the internal mammary and medial supraclavicular lymph nodes in women who had already been treated successfully for their breast cancer with standard regimens — including surgery, radiotherapy and, when needed...
AMSTERDAM—Long term survival — three to ten years — in nearly a quarter of patients with unresectable, metastatic or locally advanced melanoma treated with the cytotoxic T-lymphocyte antigen 4 (CTLA-4)-inhibiting monoclonal antibody ipilimumab was...
AMSTERDAM—A molecularly-directed approach to treatment decision-making with patients who have metastatic cancers of unknown primary site was being urged at the 2013 European Cancer Congress by researchers from Arizona who have identified biomarkers...
AMSTERDAM—People with diabetes have an increased risk of developing and dying from certain cancers, according to a meta-analysis with two million patients reported at the 2013 European Cancer Congress in Amsterdam. Researchers found a 23% increased...
LONDON—Hematopoietic stem cells are not displaced and depleted by malignant cells in patients with acute myeloid leukaemia but merely put to sleep, according to research from London published in PNAS Early Edition. Professor John Gribben from Barts...